Deciphera Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Deciphera Pharmaceuticals

03/11/2022 13:33

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 55 cents​​ per share for the quarter ended in
September. The mean expectation of eleven analysts for the
quarter was for a loss of 58 cents per share.
    * Revenue rose 54.9% to $35.97 million from a year ago;
analysts
expected $33.15 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 55 cents​.
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Deciphera Pharmaceuticals Inc shares had fallen by 10.1%
this
quarter and gained 70.3% so far this year.
    * The company reported a quarterly loss of $43.04 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $18.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:33 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.58          -0.55          Beat
 Jun. 30 2022      -0.66          -0.60          Beat
 Mar. 31 2022      -0.90          -0.80          Beat
 Dec. 31 2021      -1.38          -1.51          Missed